Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Markers of fibrosis, inflammation, and remodeling pathways in heart failure
2014
Oxidative stress, aging, and diseases
2018 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Acute Coronary Syndrome
2010
Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure
2014
Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism
2008
GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
2013
B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain
2011
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate
2004
Cardiorenal Syndrome
2008 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Growth Differentiation Factor-15: a New Biomarker in Cardiovascular Disease
2009
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Glutamate synthase: structural, mechanistic and regulatory properties, and role in the amino acid metabolism
2005 StandoutNobel
Highlights of the Year in JACC 2007
2008
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
2011
Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers
2010
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
2013
Biomarkers in Heart Failure
2008 Standout
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
2013
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
2013
Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization
2013
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome
2007
Clinical and Genetic Correlates of Growth Differentiation Factor 15 in the Community
2012
Novel biomarkers for cardiovascular risk prediction.
2017
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Diabetic Cardiomyopathy
2018 Standout
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions
2011
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
2011
Biological functions of asparagine synthetase in plants
2010 StandoutNobel
Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease
2009
Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults
2011
Incremental Prognostic Value of Biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) Score and High-Sensitivity Cardiac Troponin T in Non-ST-Elevation Acute Coronary Syndrome
2013
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart
2008
A review of theory and practice in scientometrics
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin
2009
Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
2012
Works of Tim Allhoff being referenced
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure
2007
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
2007
Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain
2008
Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure
2010
Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome
2009
Circulating Concentrations of Growth-Differentiation Factor 15 in Apparently Healthy Elderly Individuals and Patients with Chronic Heart Failure as Assessed by a New Immunoradiometric Sandwich Assay
2006
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome
2007